Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Inv. presentation
Quarterly results
Cytosorbents Corp (CTSO) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Quarterly results
08/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/01/2023 8-K Quarterly results
07/19/2023 8-K Quarterly results
07/11/2023 8-K Quarterly results
07/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial"
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/02/2023 8-K Quarterly results
04/26/2023 8-K Quarterly results
04/20/2023 8-K Quarterly results
04/06/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Consulting Agreement"
03/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "CytoSorbents Reports Fourth Quarter and Full Year 2022 Results"
12/29/2022 8-K Quarterly results
11/16/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/02/2022 8-K Quarterly results
Docs: "CytoSorbents Reports Second Quarter 2022 Financial and Operational Results PRINCETON, N.J., August 2, 2022 — CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported unaudited financial and operating results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results",
"CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms"
06/08/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
05/03/2022 8-K Quarterly results
Docs: "U.S. Public Relations Contact:"
04/29/2022 8-K Quarterly results
04/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "U.S. Public Relations Contact:"
04/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "U.S. Public Relations Contact:"
04/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "U.S. Public Relations Contact:"
03/17/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "U.S. Public Relations Contact:"
03/08/2022 8-K Quarterly results
02/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "U.S. Public Relations Contact:"
01/24/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents’ Antithrombotic Drug Removal Technology"
01/20/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "[Balance of Page Intentionally Left Blank]",
"Success Fee Letter"
01/18/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue"
12/30/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "OPEN MARKET SALE AGREEMENT SM",
"Letter re: CytoSorbents Corporation Registration Statement on Form S-3"
12/21/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "U.S. Public Relations Contact:",
"U.S. Public Relations Contact:"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy